rs759174628
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001378609.3(OTOGL):c.5014C>T(p.Arg1672Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000618 in 1,602,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001378609.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.5014C>T | p.Arg1672Ter | stop_gained | 43/59 | ENST00000547103.7 | NP_001365538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.5014C>T | p.Arg1672Ter | stop_gained | 43/59 | 5 | NM_001378609.3 | ENSP00000447211 | P1 | |
OTOGL | ENST00000646859.1 | c.4879C>T | p.Arg1627Ter | stop_gained | 47/63 | ENSP00000496036 | ||||
OTOGL | ENST00000298820.7 | c.316C>T | p.Arg106Ter | stop_gained | 4/18 | 5 | ENSP00000298820 |
Frequencies
GnomAD3 genomes AF: 0.00000668 AC: 1AN: 149766Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 246490Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 133976
GnomAD4 exome AF: 0.0000675 AC: 98AN: 1452466Hom.: 0 Cov.: 32 AF XY: 0.0000664 AC XY: 48AN XY: 722664
GnomAD4 genome AF: 0.00000668 AC: 1AN: 149766Hom.: 0 Cov.: 31 AF XY: 0.0000137 AC XY: 1AN XY: 72756
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 25, 2022 | This sequence change creates a premature translational stop signal (p.Arg1663*) in the OTOGL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OTOGL are known to be pathogenic (PMID: 23122586). This variant is present in population databases (rs759174628, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with OTOGL-related conditions. ClinVar contains an entry for this variant (Variation ID: 228384). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 30, 2015 | The p.Arg1663X variant in OTOGL has been identified by our laboratory in 2 indiv iduals with hearing loss and a second nonsense variant in OTOGL (orientation not yet determined). It has also been identified in 1/17244 East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This nonsense v ariant leads to a premature termination codon at position 1663, which is predict ed to lead to a truncated or absent protein. Loss of function of the OTOGL gene is an established disease mechanism in autosomal recessive hearing loss. In summ ary, this variant meets our criteria to be classified as pathogenic for hearing loss in an autosomal recessive manner based on the predicted impact of the varia nt. ACMG/AMP Criteria applied: PVS1; PM2; PM3. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at